Screener
UroGen Pharma URGN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's free cash flow?
- UroGen Pharma (URGN) reported free cash flow of -$33.07M in Q2 2026.
- How has UroGen Pharma's free cash flow changed year-over-year?
- UroGen Pharma's free cash flow increased by 17.3% year-over-year, from -$39.97M to -$33.07M.
- What is the long-term trend for UroGen Pharma's free cash flow?
- Over 4 years (2021 to 2025), UroGen Pharma's free cash flow has grown at a 17.4% compound annual growth rate (CAGR), from -$85.64M to -$162.73M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about UroGen Pharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude